This session will discuss EU Good Pharmacovigilance Practices (GVP) which are a set of measures drawn up to facilitate the performance of the safety monitoring of medicines in the European Union.

Have an account?

Drug Safety and Pharmacovigilance Across the Product Lifecycle

Session 15: Post-Marketing Safety Regulations – EU

Session Chair(s)

Mark Vieder, MBA, RPh

Be informed and stay engaged.